Stay updated on Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial page.

Latest updates to the Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial page
- Check5 days agoChange DetectedRevision label updated to v3.3.2 and the previous v3.3.1 label was removed. This change affects only the page's revision metadata and not the study content or data.SummaryDifference0.0%

- Check13 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0.SummaryDifference0.0%

- Check20 days agoChange DetectedThe site-wide funding-status notice was removed; this administrative update does not affect study details, eligibility criteria, outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedNo additions or deletions were detected between the two screenshots; the page content appears unchanged.SummaryDifference0.3%

- Check63 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check70 days agoChange DetectedVersion update to v3.1.0 accompanies removal of several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and no new substantive topics added.SummaryDifference0.3%

Stay in the know with updates to Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial page.